SkinBioTherapeutics (LSE:SBTX) Total Liabilities : £0.56 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Total Liabilities?

SkinBioTherapeutics's Total Liabilities for the quarter that ended in Dec. 2023 was £0.56 Mil.

SkinBioTherapeutics's quarterly Total Liabilities declined from Dec. 2022 (£0.78 Mil) to Jun. 2023 (£0.60 Mil) and declined from Jun. 2023 (£0.60 Mil) to Dec. 2023 (£0.56 Mil).

SkinBioTherapeutics's annual Total Liabilities increased from Jun. 2021 (£0.52 Mil) to Jun. 2022 (£0.61 Mil) but then declined from Jun. 2022 (£0.61 Mil) to Jun. 2023 (£0.60 Mil).

SkinBioTherapeutics Total Liabilities Historical Data

The historical data trend for SkinBioTherapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Total Liabilities Chart

SkinBioTherapeutics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

0.12

0.31

0.52

0.61

0.60

SkinBioTherapeutics Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial										0.45	0.61	0.78	0.60	0.56

SkinBioTherapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

SkinBioTherapeutics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.53	+	(0.07	+	-0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.60

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	2.594	-	1.995
	=	0.60

SkinBioTherapeutics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.501	+	(0.06	+	-0.00099999999999995
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.56

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	4.211	-	3.651
	=	0.56

SkinBioTherapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

SkinBioTherapeutics (LSE:SBTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF

Website

https://www.skinbiotherapeutics.com

SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.